close
References
  1. Singh AK, McGuirk JP. Allogeneic stem cell transplantation: a historical and scientific overview. Cancer Res. 2016;76(22):6445-6451.
  2. Van Lier YF, Van den Brink MRM, Hazenberg MD, Markey KA. The post-hematopoietic cell transplantation microbiome: relationships with transplant outcome and potential therapeutic targets. Haematologica. 2021;106(8):2042-2053.
  3. Young JAH, Weisdorf DJ. Infections in Recipients of Hematopoietic Stem Cell Transplants. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 2015;3425-3439.e5.
  4. Hooker DS, Grabe-Heyne K, Henne C, Bader P, Toumi M, Furniss SJ. Improved therapeutic approaches are needed to manage graft-versus-host disease. Clin Drug Investig. 2021;41(11):929-939.
  5. Holler E, Weber D. Microbiota and graft-versus host disease: a double-edged sword. HemaSphere. 2019;3(suppl 2):167-169.
  6. Staffas A, Burgos da Silva M, van den Brink MR. The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease. Blood. 2017;129(8):927-933. Erratum in: Blood. 2017;129(15):2204.
  7. Ferrara JLM, Chaudhry MS. GVHD: biology matters. Blood Adv. 2018;2(22):3411-3417.
  8. Ovayolu O, Ovayolu N, Kaplan E, Pehlivan M, Karadag G. Symptoms and quality of life: before and after stem cell transplantation in cancer. Pak J Med Sci. 2013;29(3):803-808.
  9. Broder MS, Quock TP, Chang E, et al. The cost of hematopoietic stem-cell transplantation in the United States. Am Health Drug Benefits. 2017;10(7):366-374.
  10. Daniels LE. Developing a home chemotherapy service. Int J Palliat Nurs. 1995;1(2):81-85.
  11. Svahn BM, Bjurman B, Myrbäck KE, Aschan J, Ringdén O. Is it safe to treat allogeneic stem cell transplant recipients at home during the pancytopenic phase? A pilot trial. Bone Marrow Transplant. 2000;26(10):1057-1060.
  12. Svahn BM, Remberger M, Myrbäck KE, et al. Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care. Blood. 2002;100(13):4317-4324.
  13. Svahn BM, Remberger M, Bergkvist K, Ringden O. Fifteen years' experience of home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2013;19(suppl 2):S339.
  14. Sung AD, Nichols KR, Messina JA, et al. Hematopoietic stem cell transplantation at home. Blood. 2017;130(suppl 1):745.
  15. A controlled study of stem cell transplantation medical home care compared to standard hospital care. Clinicaltrials.gov identifier: NCT01725022. https://clinicaltrials.gov/ct2/show/NCT01725022. Accessed November 17, 2021.
  16. Liu J, Allen DH, Lassiter M, Cao F, Sung AD, Chao NJ. Homecare encounters: an organizational response to innovative care for patients undergoing hematopoietic stem cell transplantation during COVID-19. Clin J Oncol Nurs. 2021;25(4):457-464.
  17. Sung AD, Nichols KR, Chao NJ. House calls for stem cell transplant patients during the COVID-19 pandemic. Blood. 2020;136(3):370-371.